Your invitation from the Bigpicture Project:  We are excited to invite you to the first Bigpicture Community Meeting, themed ‘The Digital Transformation of Pathology’. During the online meeting, Prof. Jeroen van der Laak, WP1 Bigpicture Project Coordinator, and Dr Julie Boisclair, WP1 EFPIA Lead, will explain the foundation of the Bigpicture project, and cover the […] The post Bigpicture Announces First Community Meeting in May first appeared on Tissuepathology.com ..read more

Indica Labs: Supercharge your Image analysis with AI-powered HALO 4.0 AI-Powered Pathology with HALO®, HALO AI, and HALO Link 4.0 Date: 6 June 2024 Time: 7:00 – 8:00 PDT | 10:00 – 11:00 EDT | 15:00 – 16:00 BST Location: Webinar Register Now Summary Join Indica Labs for this 1-hour webinar to see a live demonstration of the new versions of […] The post Indica Labs Announces June Webinar first appeared on Tissuepathology.com ..read more

From the Aiosyn blog: In the ever-changing landscape of pathology, the accurate assessment of mitotic activity plays a crucial role in diagnosing and managing various diseases, including cancer. Traditionally, pathologists manually count mitotic figures under a microscope in a labor-intensive and time-consuming process that is highly prone to inter-observer variability. However, with the rapid development […] The post Aiosyn: The benefits of AI implementation in mitotic figure counting first appeared on Tissuepathology.com ..read more

LEHI, UT, April 11, 2024 – Lumea Inc., a forefront innovator in the digital pathology space, is pleased and honored to be announced the winner of Utah’s Best in State award for Medical Innovation. Lumea operates right in the heart of Silicon Slopes, recently named by the Wall Street Journal the top tech hub in the United States. When Stanford-trained […] The post Lumea recognized as Best of State Winner for Medical Innovation first appeared on Tissuepathology.com ..read more

PredxBio, Inc., a leader in spatially intelligent biology, and PictorLabs, Inc., a leading digital pathology firm pioneering AI-powered virtual staining technology, are pleased to announce a transformative partnership aimed at revolutionizing cancer research, diagnosis, and treatment. PITTSBURGH and LOS ANGELES, April 9, 2024 /PRNewswire-PRWeb/ — PredxBio, Inc., a leader in spatially intelligent biology, and PictorLabs, Inc., a leading digital […] The post PredxBio and PictorLabs Forge Strategic Partnership to Advance Cancer Research and Diagnostics with Next Generation Spa ..read more

CHICAGO–(BUSINESS WIRE)–Nucleai, a spatial AI biomarker company that deciphers cellular conversations and maps cellular interactions within tissue samples to predict therapeutic outcomes, today announced a strategic collaboration with GoPath Diagnostics, a leading full-service digital pathology and molecular diagnostics laboratory. This collaboration aims to offer AI-powered digital pathology solutions for clinical trials and diagnostics and foster innovative […] The post Nucleai and GoPath Diagnostics Announce Strategic Collaboration to Provide Integrated AI-powered Digital Pathology Sol ..read more

Indica Labs and Molecular Instruments Announce Partnership to Advance AI-Powered Quantitative Image Analysis with HCR™ RNA-ISH Albuquerque, NM, and Los Angeles, CA 5 April 2024 — Indica Labs, a leading provider of AI-powered digital pathology solutions, and Molecular Instruments® (MI), the inventor of the HCR™ Imaging technology, announce a new partnership to co-market compatibility between […] The post Indica Labs and Molecular Instruments Announce Partnership to Advance AI-Powered Quantitative Image Analysis with HCR™ RNA-ISH first appeared on Tissuepathology.com ..read more

The Extension Funds Nucleai to Advance Its First-in-Class Spatial AI Biomarker in Active Clinical Enrollment Investment Expands Deployments of AI-Powered Spatial Biomarker Technology, Strengthening Companion Diagnostics for ADCs, Bi-specifics, and Immunotherapies M Ventures is the corporate strategic venture arm of Merck KGaA, Darmstadt, Germany April 03, 2024 07:00 AM Eastern Daylight Time CHICAGO–(BUSINESS WIRE)–Nucleai, a […] The post Merck’s Corporate Venture M Ventures Arm Backs Nucleai to Advance Its First-in-class Spatial AI Biomarker in Active Clinical Enrollment first appeared on Tiss ..read more

From the Lumea Podcast – Ask A Pathologist:  Welcome to our seventh episode of the Ask a Pathologist Podcast, Innovators in Action. We had the privilege to interview Dr. Todd Randolph about artificial intelligence and its current and future role in digital pathology. Dr. Todd Randolph holds board certification in anatomic pathology and cytopathology. He […] The post Lumea Podcast: Artificial Intelligence In Digital Pathology first appeared on Tissuepathology.com ..read more

PreciseDx: Sponsored collaboration will focus on evaluating the ability of PreciseBreast™ to accurately predict breast cancer recurrence for those patients with TNBC  NEW YORK, April 2, 2024 /PRNewswire/ — PreciseDx®, a leading innovator in oncology diagnostics leveraging Artificial Intelligence (AI) for revolutionary, morphology-driven disease analysis, today announced a sponsored research collaboration with UCLA’s Department of Pathology and Laboratory Medicine in Los Angeles to evaluate PreciseBreast’s™ ability […] The post UCLA an ..read more